1. Koda-Kimble MA, Young LY, Alldredge BK, Corelli RL, Ernst ME, Guglielmo BJ, Jacobson PA, Kradjan WA, Williams BR (2009) Applied therapeutics: the clinical use of drugs, seizure disorders, 2. Lippincott Williams & Wilkins, Philadelphia, pp 1387–1388
2. Brunton LL, Chabner BA, Knollmann BC (2006) Goodman and Gilman’s the pharmacological basis of therapeutics, pharmacotherapy of the epilepsies, 1. McGraw-Hill, New York, p 583
3. Hitiris N, Brodie MJ (2006) Modern antiepileptic drugs: guidelines and beyond. Curr Opin Neurol 19:175–180
4. Vezzani A, Bartfai T, Bianchi M, Rossetti C, French J (2011) Therapeutic potential of new antiinflammatory drugs. Epilepsia 52:67–69
5. Javadian N, Rahimi N, Javadi-Paydar M, Doustimotlagh AH, Dehpour AR (2016) The modulatory effect of nitric oxide in pro-and anti-convulsive effects of vasopressin in PTZ-induced seizures threshold in mice. Epilepsy Res 126:134–140